Valuation: Virbac

Market Cap 2.87B 3.26B 2.64B 2.47B 4.63B 308B 4.73B 31.76B 12.29B 152B 12.25B 11.98B 528B P/E 2026 *
17x
P/E 2027 * 15.2x
Enterprise Value 2.99B 3.4B 2.75B 2.58B 4.82B 321B 4.93B 33.11B 12.8B 158B 12.76B 12.48B 550B EV / Sales 2026 *
1.93x
EV / Sales 2027 * 1.76x
Free-Float
49.03%
Yield 2026 *
0.51%
Yield 2027 * 0.6%
1 day-0.15%
1 week+3.79%
Current month-4.60%
1 month-5.66%
3 months-3.53%
6 months-2.84%
Current year-4.34%
1 week 333
Extreme 333
344.5
1 month 327.5
Extreme 327.5
370
Current year 326.5
Extreme 326.5
389.5
1 year 296
Extreme 296
389.5
3 years 232.5
Extreme 232.5
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap.
22/04/24Sell

Chief Executive Officer

1,688 0.0200%
22/04/24Sell

Chief Executive Officer

810 0.0096%
22/04/24Sell

Chief Executive Officer

140 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%+3.79%+7.89%+24.14% 3.27B
-2.22%-3.33%-51.61%-54.81% 32.62B
+0.82%+1.45%+78.56%+150.20% 12.17B
-2.32%-7.83%-8.40%+13.35% 4.1B
-5.30%-2.80%+41.58%+23.54% 1.94B
-2.32%-0.51%-26.85%-1.96% 1.64B
-0.44%-0.50%+28.04%+135.26% 1.29B
-2.97%-5.39%-25.53%-19.03% 990M
+0.70%+5.39%0.00%-18.01% 951M
-1.33%-6.60%-18.29%-49.32% 905M
Average -1.55%-1.27%+2.54%+20.34% 5.99B
Weighted average by Cap. -1.51%-0.98%-11.77%+5.18%

Financials

2026 *2027 *
Net sales 1.55B 1.76B 1.43B 1.33B 2.5B 166B 2.55B 17.14B 6.63B 81.95B 6.61B 6.46B 285B 1.64B 1.87B 1.51B 1.41B 2.65B 176B 2.7B 18.18B 7.03B 86.89B 7.01B 6.85B 302B
Net income 167M 190M 154M 144M 270M 17.94B 276M 1.85B 716M 8.85B 714M 698M 30.76B 190M 216M 175M 164M 307M 20.42B 314M 2.11B 816M 10.08B 813M 795M 35.03B
Net Debt 121M 138M 112M 104M 195M 12.99B 200M 1.34B 519M 6.41B 517M 506M 22.28B 26.49M 30.15M 24.42M 22.85M 42.79M 2.84B 43.7M 294M 114M 1.4B 113M 111M 4.88B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
26/06/26 EUR 342.00 -0.15% 1,777
25/06/26 EUR 342.50 +0.59% 3,575
24/06/26 EUR 340.50 +1.49% 2,957
23/06/26 EUR 335.50 -0.74% 4,582
22/06/26 EUR 338.00 -0.73% 8,443
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
342.00EUR
Average target price
412.88EUR
Spread / Average Target
+20.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock